Status:
RECRUITING
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Santelys Association
Région Nord-Pas de Calais, France
Conditions:
Thoracic Aortic Aneurysm
Eligibility:
All Genders
45-80 years
Brief Summary
Thoracic aneurysm is a silent disease with a potential mid-term high risk of death or major complications. Few data are available on the real incidence of major complications in case of small and mode...
Eligibility Criteria
Inclusion
- Documentation of an aortic root aneurysm \> 40 mm
- Agreement to participate to a longitudinal study and available for a 5 years follow-up
Exclusion
- Presence of comorbidities or pathology with a prognosis of less than 1 year
- Personal or family history of genetically documented elastic tissue disease or patient meeting the GAND clinical criteria suggestive of Marfan disease
- High-grade mitra-aortic valve disease, even if asymptomatic
- Unbalanced hypertension ≥ 180/110 mmHg
- Aneurysm (regardless of thoracic or abdominal location) ≥ 50 mm
- Aneurysm (regardless of thoracic or abdominal location) with documented progression of more than 5 mm over one year
- History of aortic surgery or endovascular intervention and history of type B aortic dissection of medical treatment
- Renal insufficiency on dialysis, or GFR\< 30 ml/mn (CKD-EPI)
Key Trial Info
Start Date :
April 18 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2031
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT05395598
Start Date
April 18 2024
End Date
October 1 2031
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Lille
Lille, Please Choose..., France, 59037